NCT05826535 2026-04-17Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell LymphomaLyell Immunopharma, Inc.Phase 1/2 Recruiting270 enrolled
NCT01384513 2026-04-15A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological MalignanciesThomas Jefferson UniversityPhase 2 Completed40 enrolled 15 charts
NCT03269669 2026-04-13Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular LymphomaNational Cancer Institute (NCI)Phase 2 Active not recruiting73 enrolled
NCT00428142 2026-03-27Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's LymphomaCanadian Cancer Trials GroupPhase 2 Completed95 enrolled